Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

InxMed Receives $10M Debt Financing from SPD Silicon Valley Bank to Advance FAK Inhibitor IN10018

February 24, 2025
CompanyDeals

Frontera Therapeutics Raises $160M in Series B to Advance Gene Therapy FT-001

February 24, 2025
CompanyDrug

DAC Biotech’s DXC005 ADC Doses First Patient in Beijing Cancer Hospital Trial

February 24, 2025
Company

J&J Q2 Sales Rise 8% but Profits Plunge 23% Amid China COVID Lockdowns

February 24, 2025
Company

Novartis Q2 Results Show 5% Growth, Led by Entresto and Cosentyx

February 24, 2025
CompanyDeals

Aidea Pharmaceutical Acquires 19.96% ND Pharm Stake to Boost Urokinase Business

February 24, 2025
Policy / Regulatory

NHSA Issues New Medical Service Pricing Policy to Enhance Public Welfare and Innovation

February 24, 2025
CompanyMedical Device

MicroPort CardioFlow Completes First Clinical Use of Dry Valve Transcatheter Mitral Valve System

February 24, 2025
Company

WuXi Biologics to Build $1.4B CRDMO Hub in Singapore, Creating 1,500 Jobs

February 24, 2025
CompanyDeals

Antengene and Celularity Partner on Bispecific Antibody and NK Cell Therapy Combo

February 24, 2025
Drug

Kexing Pharmaceutical Launches Phase III Influenza Vaccine Study in Chile

February 24, 2025
Drug

Henlius Biotech’s HLX14 Biosimilar Wins TGA Approval for Global Phase III Osteoporosis Study

February 24, 2025
1 2 … 5 6 7 8 9 … 20 21
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up